InnovAge Holding Corp. (NASDAQ: INNV), a healthcare company specializing in medical care facilities, presents a unique opportunity for investors looking to explore the growing sector of senior healthcare. With a..
Niagen Bioscience, Inc. (NAGE) is capturing the attention of investors with a compelling 117.34% potential upside, as indicated by the average analyst target price of $16.04. This biotechnology firm, headquartered..
Evolus, Inc. (NASDAQ: EOLS), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, has been capturing the attention of investors with its promising..
Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology company, is capturing investor attention with its promising pipeline in targeted cancer therapies. Based in Bothell, Washington, Immunome focuses on innovative treatments for..
Replimune Group, Inc. (NASDAQ: REPL) is capturing attention in the biotech sector with its innovative approach to treating cancer through oncolytic immunotherapies. Headquartered in Woburn, Massachusetts, this clinical-stage company is..
Investors with an eye on the healthcare sector, particularly in the cutting-edge realm of cancer diagnostics and research, are likely familiar with Personalis, Inc. (NASDAQ: PSNL). This Fremont, California-based company..
CureVac N.V. (NASDAQ: CVAC) is a biopharmaceutical company at the forefront of mRNA-based therapeutic development. Based in Tübingen, Germany, CureVac has carved a niche in the dynamic biotechnology industry, focusing..
Opthea Limited (NASDAQ: OPT), a crucial player in the biotechnology sector, is making waves with its innovative approach to treating serious eye conditions such as wet age-related macular degeneration (Wet..
Pharvaris N.V. (PHVS), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to tackling rare diseases. Headquartered in Zug, Switzerland, this late-stage biopharmaceutical company..
Auna SA (AUNA), a prominent player in the healthcare sector, operates a network of hospitals and clinics across Mexico, Peru, and Colombia. With its headquarters in Luxembourg, this medical care..
AnaptysBio, Inc. (NASDAQ: ANAB) is capturing the attention of investors with a compelling narrative of innovation in the healthcare sector, specifically in biotechnology. Based in San Diego, California, this clinical-stage..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a key player in the biotechnology sector, is capturing investor attention with its focus on developing innovative treatments for neurodegenerative diseases and endocrine disorders. With..
iRadimed Corporation (NASDAQ: IRMD) stands out as a niche player in the healthcare sector, specializing in MRI-compatible medical devices. With its roots firmly planted in the United States and operational..
CorMedix Inc. (NASDAQ: CRMD) is making waves in the biopharmaceutical sector, capturing investor attention with its significant growth potential. With a market capitalization of $862.55 million, this healthcare-focused company is..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands as a notable player in the biotechnology sector, with its innovative approach to cell programming. Headquartered in Boston, Massachusetts, Ginkgo Bioworks is at..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.58..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a leader in the biotechnology sector, is making waves with its innovative approach to treating rare diseases. With a market capitalization of $522.62 million, this..
Community Health Systems, Inc. (NYSE: CYH), a prominent player in the U.S. healthcare sector, operates a network of general acute care hospitals. Headquartered in Franklin, Tennessee, the company offers a..
Fulgent Genetics, Inc. (FLGT), a prominent player in the Healthcare sector, particularly in Diagnostics & Research, offers an intriguing investment proposition with a potential upside of 10.63% according to current..
